Scientific MOOCs follower. Author of Airpocalypse, a techno-medical thriller (Out Summer 2017)


Welcome to the digital era of biology (and to this modest blog I started in early 2005).

To cure many diseases, like cancer or cystic fibrosis, we will need to target genes (mutations, for ex.), not organs! I am convinced that the future of replacement medicine (organ transplant) is genomics (the science of the human genome). In 10 years we will be replacing (modifying) genes; not organs!

Anticipating the $100 genome era and the P4™ medicine revolution. P4 Medicine (Predictive, Personalized, Preventive, & Participatory): Catalyzing a Revolution from Reactive to Proactive Medicine.

I am an early adopter of scientific MOOCs. I've earned myself four MIT digital diplomas: 7.00x, 7.28x1, 7.28.x2 and 7QBWx. Instructor of 7.00x: Eric Lander PhD.

Upcoming books: Airpocalypse, a medical thriller (action taking place in Beijing) 2017; Jesus CRISPR Superstar, a sci-fi -- French title: La Passion du CRISPR (2018).

I love Genomics. Would you rather donate your data, or... your vital organs? Imagine all the people sharing their data...

Audio files on this blog are Windows files ; if you have a Mac, you might want to use VLC (http://www.videolan.org) to read them.

Concernant les fichiers son ou audio (audio files) sur ce blog : ce sont des fichiers Windows ; pour les lire sur Mac, il faut les ouvrir avec VLC (http://www.videolan.org).

The oPhone, a phone for odors, could help treat Alzheimer's

The oPhone does not work like a normal cell phone. It does not transmit or receive sounds.
Instead, the cylinder-shaped device consists of a set of disposable "oChips" that can store and emit hundreds of different odors for between 20 and 30 seconds.
The fragrances are created by Marlène Staiger, an aroma expert at a laboratory in France called Le Laboratoire. She deconstructs the scents before capturing them in wax.

http://www.medicalnewstoday.com/articles/272565.php
Publié par le
Libellés : , , ,

Aucun commentaire:

Enregistrer un commentaire

Inscription à : Publier les commentaires (Atom)